Takeyoshi Masahiro, Sawaki Masakuni, Yamasaki Kanji, Kimber Ian
Chemicals Assessment Center, Chemicals Evaluation and Research Institute, 3-822, Ishii-machi, Hita-shi, Oita, 8770061, Japan.
Toxicology. 2003 Sep 30;191(2-3):259-63. doi: 10.1016/s0300-483x(03)00255-5.
The murine local lymph node assay (LLNA) is used for the identification of chemicals that have the potential to cause skin sensitization. However, it requires specific facility and handling procedures to accommodate a radioisotopic (RI) endpoint. We have developed non-radioisotopic (non-RI) endpoint of LLNA based on BrdU incorporation to avoid a use of RI. Although this alternative method appears viable in principle, it is somewhat less sensitive than the standard assay. In this study, we report investigations to determine the use of statistical analysis to improve the sensitivity of a non-RI LLNA procedure with alpha-hexylcinnamic aldehyde (HCA) in two separate experiments. Consequently, the alternative non-RI method required HCA concentrations of greater than 25% to elicit a positive response based on the criterion for classification as a skin sensitizer in the standard LLNA. Nevertheless, dose responses to HCA in the alternative method were consistent in both experiments and we examined whether the use of an endpoint based upon the statistical significance of induced changes in LNC turnover, rather than an SI of 3 or greater, might provide for additional sensitivity. The results reported here demonstrate that with HCA at least significant responses were, in each of two experiments, recorded following exposure of mice to 25% of HCA. These data suggest that this approach may be more satisfactory-at least when BrdU incorporation is measured. However, this modification of the LLNA is rather less sensitive than the standard method if employing statistical endpoint. Taken together the data reported here suggest that a modified LLNA in which BrdU is used in place of radioisotope incorporation shows some promise, but that in its present form, even with the use of a statistical endpoint, lacks some of the sensitivity of the standard method. The challenge is to develop strategies for further refinement of this approach.
小鼠局部淋巴结试验(LLNA)用于鉴定有潜在皮肤致敏性的化学物质。然而,它需要特定的设施和处理程序来适应放射性同位素(RI)终点检测。我们基于溴脱氧尿苷(BrdU)掺入开发了LLNA的非放射性同位素(non-RI)终点检测方法,以避免使用放射性同位素。尽管这种替代方法原则上似乎可行,但它比标准检测方法的灵敏度略低。在本研究中,我们报告了在两个独立实验中使用统计分析来提高用α-己基肉桂醛(HCA)进行的非RI LLNA程序灵敏度的研究。因此,根据标准LLNA中作为皮肤致敏剂分类的标准,替代的非RI方法需要大于25%的HCA浓度才能引发阳性反应。然而,在两个实验中替代方法对HCA的剂量反应都是一致的,并且我们研究了使用基于LNC周转率诱导变化的统计学显著性而非SI为3或更高的终点检测是否可能提供更高的灵敏度。此处报告的结果表明,在两个实验中的每一个中,当小鼠暴露于25%的HCA后,至少记录到了显著反应。这些数据表明,这种方法可能更令人满意——至少在测量BrdU掺入时是这样。然而,如果采用统计终点,这种对LLNA的修改比标准方法的灵敏度要低得多。综合此处报告的数据表明,用BrdU代替放射性同位素掺入的改良LLNA显示出一些前景,但就其目前形式的当前形式而言,即使使用统计终点,仍缺乏标准方法的一些灵敏度。挑战在于制定进一步完善这种方法的策略。